Amphastar Pharmaceuticals AMPH Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's software and technology licenses, net?
- Amphastar Pharmaceuticals (AMPH) reported software and technology licenses, net of $33.48M in Q1 2026.
- How has Amphastar Pharmaceuticals's software and technology licenses, net changed year-over-year?
- Amphastar Pharmaceuticals's software and technology licenses, net increased by 45.6% year-over-year, from $22.99M to $33.48M.
- What is the long-term trend for Amphastar Pharmaceuticals's software and technology licenses, net?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's software and technology licenses, net has grown at a 42.8% compound annual growth rate (CAGR), from $5.25M to $31.14M.